• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number VBJR052502A
Device Problem Detachment of Device or Device Component (2907)
Patient Problems Stenosis (2263); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/12/2022
Event Type  malfunction  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium apl, which in covalently bound to the device surface and is essentially|non-eluting.
 
Event Description
The following information was reported to gore: on (b)(6) 2022, a gore® viabahn® endoprosthesis (vsx device) was intended for use in the left superficial femoral artery for treatment of stenosis.After the device was successfully implanted, the physician removed the delivery catheter.Upon removal of the delivery catheter it was discovered that the distal tip had separated from the catheter inside the patient.An angiogram was performed and the distal tip was located in the implanted device.The decision was made to advance an additional 5mm x 5cm vsx device and pin the distal tip to the wall of the previously implanted vsx device.A final angiogram was performed to verify that the distal tip was pinned against the wall and the procedure was completed.The patient did not experience any adverse consequences.
 
Manufacturer Narrative
Section h6 updated to reflect completion of investigation.Manufacturing records were reviewed, and the device met all pre-release specifications.The cause of the reported primary device failure mode, distal tip separation during removal, could not be confirmed.No items were returned for evaluation; however, the device serial number was provided allowing for a review of the bonding process for the device.Review of process data yielded no evidence of a missing distal tip bond.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.
 
Manufacturer Narrative
Revised h6: health effect - clinical code and investigation findings code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
nick lafave
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14606369
MDR Text Key293466433
Report Number2017233-2022-02991
Device Sequence Number1
Product Code NIP
UDI-Device Identifier00733132623938
UDI-Public00733132623938
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberVBJR052502A
Device Catalogue NumberVBJR052502A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/12/2022
Initial Date FDA Received06/06/2022
Supplement Dates Manufacturer Received07/13/2022
08/18/2022
Supplement Dates FDA Received07/13/2022
09/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/18/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age74 YR
Patient SexMale
-
-